Structural factors contributing to DM susceptibility of MHC class II/peptide complexes

Journal of Immunology

Volumn 169, Issue 9, 2002, Pages 5109-5117

  Belmares, Michael P ^a   Busch, Robert ^a   Wucherpfennig, Kai W ^a   McConnell, Harden M ^a   Mellins, Elizabeth D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DM ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANTIGEN BINDING; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DISSOCIATION; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; MOLECULAR STABILITY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BINDING; PROTEIN SYNTHESIS; RNA EDITING; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION;

EID: 0036838687     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.9.5109     Document Type: Article

References (60)

1. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: Providing ligands for T-lymphocyte activation. Cell 76:287.
2. Delon, J., and R. N. Germain. 2000. Information transfer at the immunological synapse. Curr. Biol. 10:R923.
3. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: First listing, Immunogenetics 41:178.
4. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
5. Pinet. V. M., and E. O. Long. 1998. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur. J. Immunol. 28:799.
6. Santambrogio, L., A. K. Sato, G. J. Carven. S. L. Belyanskaya, J. L. Strominger, and L. J. Stem. 1999. Extracellular antigen processing and presentation by immature dendritic cells. Proc. Natl. Acad. Sci. USA 96:15056.
7. Amdt, S. O., A. B. Vogt, S. Markovic-Plese, R. Martin, G. Moldenhauer, A. Wölpl, Y. Sun. D. Schadendorf, G. J. Hämmerling, and H. Kropshofer. 2000. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 19:1241.
8. Dessen, A., C. M. Lawrence, S. Cupo, D. M. Zaller, and D. C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7:473.
9. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently linked bound single peptides. Science 272:1001.
10. k l complex with a dominant epitope in lysozyme. Immunity 8:305.
11. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stem, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three dimensional structure of the human class 11 histocompatibility antigen HLA-DRI. Nature 364:33.
12. Smith, K. J., J. Pyrdol, L. Gauthier, D. C. Wiley, and K. W. Wucherpfennig. 1998. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med. 188:1511.
13. Hammer, J., F. Gallazi,. E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847.
14. Marshall, K. W., K. J. Wilson, J. Liang. A. Woods, D. Zaller, and J. B. Rothbard. 1995. Prediction of peptide affinity to HLA DRB1*0401. J. Immunol. 154:5927.
15. Borras-Cuesta, F., J. Golvano, M. Garcia-Granero, P. Sarobe, J. Riezu-Boj, E. Huarte, and J. Lasarte. 2000. Specific and general HLA-DR binding motifs: Comparison of algorithms. Hum. Immunol. 61:266.
16. Mallios, R. R. 2001. Predicting class II MHC/peptide multilevel binding with an iterative stepwise discriminant analysis meta-algorithm. Bioinformatics 17:942.
17. Stem, L., G. Brown. T. Jardetzky, J. Gorga, R. Urban. J. Strominger, and D. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DRI complexed with an antigenic peptide from influenza virus. Nature 368:215.
18. McFarland, B. J., C. Beeson, and A. J. Sant. 1999. A single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. J. Immunol. 163:3567.
19. McFarland, B. J., J. F. Katz, C. Beeson, and A. J. Sant. 2001. Energetic asymmetry among hydrogen bonds in MHC class II-peptide complexes. Proc. Natl. Acad. Sci. USA 98:9231.
20. Sant, A. J., C. Beeson. B. J. McFarland, J. Cao, S. Ceman, P. W. Bryant, and S. H. Wu. 1999. Individual hydrogen bonds play a critical role in MHC class II:peptide interactions: Implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange, Immunol. Rev. 172:239.
21. Busch, R., R. C. Doebele, N. S. Patil, A. Pashine, and E. D. Mellins. 2000. Accessory molecules for MHC class II peptide loading. Curr. Opin. Immunol. 12:99.
22. Busch, R., and E. D. Mellins. 1996. Developing and shedding inhibitions: How MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51.
23. Nanda, N. K., and A. J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192:781.
24. Katz, J. F., C. Stebbins, E. Appella, and A. J. Sant. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184:1747.
25. Lightstone, L., R. Hargreaves, G. Bobek, M. Peterson, G. Aichinger, G. Lombardi, and R. Lechler. 1997. In the absence of the invariant chain. HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA 94:5772.
26. Kropshofer, H., A. B. Vogt, G. Moldenhauer, J. Hammer, J. S. Blum, and G. J. Hämmerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15:6144.
27. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
28. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153.
29. Kropshofer, H., S. O. Arndt. G. Moldenhauer, G. J. Hämmerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293.
30. Sloan, V. S., P. Cameron, G. Porter, M. Gammon. M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
31. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class 11 α-β dimers and facilitates peptide loading. Cell 82:155.
32. Jensen, P. E., D. A. Weber, W., P. Thayer, L. E. Westerman, and C. T. Dao. 1999. Peptide exchange in MHC molecules. Immunol. Rev. 172:229.
33. Kropshofer, H., G. J. Hämmerling, and A. B. Vogt. 1999. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172:267.
34. Vogt, A. B., H. Kropshofer. G. Moldenhauer. and G. J. Hämmerling. 1996. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLADM. Proc. Natl. Acad. Sci. USA 93:9724.
35. Mosyak, L., D. M. Zaller, and D. C. Wiley. 1998. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9:377.
36. Fremont, D. H., F. Crawford, P. Marrack, W. A. Hendrickson, and J. Kappler. 1998. Crystal structure of mouse H2-M. Immunity 9:385.
37. Doebele, R. C., R. Busch, H. M. Scott, A. Pashine, and E. D. Mellins. 2000. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13:517.
38. Siklodi, B., A. B. Vogt, H. Kropshofer, F. Falcioni, M. Molina, D. R. Bolin, R. Campbell, G. J. Hämmerling, and Z. A. Nagy. 1998. Binding affinity independent contribution of peptide length to the stability of pepfide-HLA-DR complexes in live antigen presenting cells. Hum. Immunol. 59:463.
39. Raddrizzani, L., E. Bono, A. B. Vogt, H. Kropshofer, F. Gallazzi. T. Stumolio, G. J. Hämmerling, F. Sinigaglia, and J. Hammer. 1999, Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM. Eur. J. Immunol. 29:660.
40. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
41. Hall, F. C., J. D. Rabinowitz, M. P. Belmares, R. Busch, N. Patil, A. Cope, S. Patel, G. Sonderstrup, E. D. Mellins, and H. M. McConnell. 2002. Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes. Eur. J. Immunol. 32:662.
42. Chou, C. L., and S. Sadegh-Nasseri. 2000. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J. Exp. Med. 192:1697.
43. Gauthier, L., K. J. Smith, J. Pyrdol, A. Kalandadze, J. L. Strominger, D. C. Wiley, and K. W. Wucherpfennig. 1998. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. Proc. Natl. Acad. Sci. USA 95:11828.
44. Kalandadze, A., M. Galleno, L. Foncerrada. J. L. Strominger, and K. W. Wucherpfennig. 1996. Expression of recombinant HLA-DR2 molecules: Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR α-β heterodimers. J. Biol. Chem. 271:20156.
45. Busch, R., Z. Reich, D. M. Zaller, V. Sloan, and E. D. Mellins. 1998. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM. J. Biol. Chem. 273:27557.
46. Zarutskie, J. A., R. Busch, Z. Zavala-Ruiz, M. Rushe, E. D. Mellins, and L. J. Stern. 2001. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc. Natl. Acad. Sci. USA 98:12450.
47. Schmitt, L., J. J. Boniface, M. M. Davis, and H. M. McConnell. 1998. Kinetic isomers of a class II MHC-peptide complex. Biochemistry 37:17371.
48. Rabinowitz, J. D., M. Vrljic, P. M. Kasson, M. N. Liang, R. Busch, J. J. Boniface, M. M. Davis, and H. M. McConnell. 1998. Formation of a highly peptide-receptive state of class 11 MHC. Immunity 9:699.
49. Belmares, M. P., J. D. Rabinowitz, W. Liu. E. D. Mellins, and H. M. McConnell. 2000. pH stability of HLA-DR4 complexes with antigenic peptides. Biochemistry 39:14558.
50. Busch, R., R. C. Doebele, E. von Scheven, J. Fahrni, and E. D. Mellins. 1998. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: Implications for assembly, maturation and function. J. Immunol. 160:734.
51. Vos, K., A. M. Miltenburg, K. E. van Meijgaarden, M. van den Heuvel, D. G. Elferink, P. J. van Galen, R. A. van Hogezand, E. van Vliet-Daskalopoulou, T. H. Ottenhoff, F. C. Breedveld, et al. 2000. Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions. Rheumatology 39:1326.
52. Cope, A. P., S. D. Patel, H. F., M. Congia, H. A. Hubers, G. F. Verheijden, A. M. Boots, R. Menon. M. Trucco, A. W. Rijnders, and G. Sonderstrup. 1999. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum. 42:1497.
53. Rosloniec, E. F., D. D. Brand, L. K. Myers, Y. Esaki, K. B. Whittington, D. M. Zaller, A. Woods, J. M. Stuart, and A. H. Kang. 1998. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J. Immunol. 160:2573.
54. Wucherpfennig, K. W., J. Zhang, C. Witek, M. Matsui, Y. Modabber, K. Ota, and D. A. Hafler. 1994. Clonal expansion and persistence of human T cells specific for an immunodominant myeling basic protein peptide. J. Immunol. 152:5581.
55. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain derived peptide, CLIP, is regulated by allelic polymorphism in class 11. J. Exp. Med. 181:677.
56. Liang, M. N., C. Lee, Y. Xia, and H. M. McConnell. 1996. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC. Biochemistry 35:14734.
57. Patil, N. S., A. Pashine, M. P. Belmares, W. Liu, B. Kaneshiro, J. Rabinowitz. H. McConnell, and E. D. Mellins. 2001. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles. J. Immunol. 167:7157.
58. Weber, D. A., C. T. Dao, J. Jun, J. L. Wigal, and P. E. Jensen. 2001. Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J. Immunol. 167:5167.
59. Kasson, P. M., J. D. Rabinowitz, L. Schmitt, M. M. Davis, and H. McConnell. 2000. Kinetics of peptide binding to the class II MHC protein I-Ek. Bioehemistry 39:1048.
60. Zarutskie, J. A., A. K. Sato, M. M. Rushe, I. C. Chan, A. Lomakin, G. B. Benedek, and L. J. Stem. 1999. A conformational change in the human major histocompatability complex protein HLA-DRI induced by peptide binding. Biochemistry 38:5878.